Institute of Nutritional Sciences, Molecular Nutrition Unit,
Technical University of Munich, Freising-Weihenstephan, Germany
We have tested 33 flavonoids, occurring ubiquitously in foods of plant
origin, for their ability to alter the transport of the
-lactam
antibiotic cefixime via the H+-coupled intestinal peptide
transporter PEPT1 in the human intestinal epithelial cell line Caco-2.
Of the flavonoids tested, quercetin, genistein, naringin, diosmin,
acacetin, and chrysin increased uptake of [14C]cefixime
dose dependently by up to 60%. All other flavonoids were either
without effect or decreased the absorption of cefixime. Quercetin was
shown to increase the Vmax of cefixime
influx without changing the apparent Km for
transport. However, the expected concomitant increase in intracellular
acidification due to PEPT1-mediated cefixime/H+-cotransport
was less pronounced in the presence of quercetin. This suggested that
pH regulatory systems such as apical
Na+/H+-exchange could be activated by quercetin
and maintain the proton-motive driving force for cefixime uptake. Since
quercetin and genistein have been shown to inhibit epidermal growth
factor (EGF)-receptor tyrosine kinases, we applied tyrphostin 25 to
prove whether such an inhibition could explain the stimulatory effects
seen on cefixime uptake. It was found that tyrphostin 25 simulated the
effects of quercetin by increasing cefixime absorption due to
maintenance of the transmembrane pH gradient. In conclusion, our
studies show that flavonoids with EGF-receptor tyrosine kinase
inhibitory activities enhance the intestinal absorption of the
-lactam antibiotic cefixime in Caco-2 cells by activation of apical
Na+/H+-exchange and a concomitant increase of
the driving force for PEPT1.
 |
Introduction |
Food
ingredients may interact with the absorption of drugs by a variety of
mechanisms and may substantially affect their pharmacokinetics. Besides
the effects that food exerts on gastric pH, gastric emptying etc.,
components of food can alter drug absorption, e.g., through alterations
in drug solubility, by affecting presystemic intestinal metabolism, or
by interaction with drug transporters (Evans, 2000
; Aronson, 2001
).
Ingredients of grapefruit juice, especially, have achieved much
attention when it was found that grapefruit juice enhanced the oral and
systemic availability of a variety of drugs when compared with other
juices or water (Ameer and Weintraub, 1997
; Bailey et al., 1998
). The
ingredients responsible for those effects were suggested to be
flavonoids, such as naringin and furanocoumarines, like
6',7'-dihydroxybergamottin (Eagling et al., 1999
). Effects on systemic
availability by grapefruit juice components were explained by the acute
inhibition and down-regulation of phase-I drug-metabolizing enzymes,
mainly CYP3A4 (Eagling et al., 1999
). Although the in vitro findings
supported naringin or 6',7'-dihydroxybergamottin as being active
ingredients, neither of these compounds contributed significantly to
the observed grapefruit juice-drug interactions in human volunteers
(Bailey et al., 1993
, 1998
). It therefore was suggested that other
plant components, mainly other flavonoids, could be the active
principle. In addition to affecting the presystemic metabolism of
drugs, flavonoids may also be able to alter the activity of epithelial
drug transporters and thereby modulate the absorption of drugs from the
intestine (Kane and Lipsky, 2000
). This has so far been shown for a
variety of flavonoids in the cases of the P-glycoprotein (Castro and
Altenberg, 1997
; Conseil et al., 1998
; Mitsunaga et al., 2000
; Sadzuka
et al., 2000
) and the multidrug resistance-associated proteins
(Hooijberg et al., 1997
; Walgren et al., 2000
), which are drug efflux
pumps transporting a huge variety of xenobiotics (Seelig, 1998
; Seelig et al., 2000
).
Especially for drugs displaying generally low oral availabilities, the
enhancement of absorption by naturally occurring food ingredients, such
as flavonoids, might be beneficial. We have therefore focused on
dianionic
-lactam antibiotics such as cefixime, which is mainly used
for treatment of respiratory tract infections (Verghese et al., 1990
).
It shows a comparably low oral availability in vivo (Bergan, 1984
;
Faulkner et al., 1988
), and its intestinal absorption is like that of
all orally active
-lactam antibiotics, determined by the interaction
with the intestinal peptide transporter PEPT1 (Bretschneider et al.,
1999
). We have previously shown that the lower oral availability of
cefixime compared with that of zwitterionic
-aminocephalosporins is
due to a low transport rate by PEPT1 under physiological pH conditions
(Wenzel et al., 1996
). Therefore, increasing the PEPT1-mediated
transport for cefixime by flavonoids could provide a principle for the
enhancement of its oral availability. Moreover, as interactions of
flavonoids with the intestinal peptide transporter PEPT1 have never
been studied, nothing is known on potential interactions of such
components with drugs that utilize PEPT1 for uptake into the body.
We therefore investigated 33 selected flavonoids of the flavone,
flavonol, flavanone, and isoflavone subgroups for their ability to
modulate uptake of [14C]cefixime by PEPT1 in
Caco-2 cells. Moreover, by measurements of intracellular pH
(pHin) we assessed whether effects on transport were directly caused by interaction of the test compounds with the
PEPT1-protein or secondarily caused by alterations in
pHin homeostasis and the proton-motive driving
force required for cefixime uptake.
 |
Experimental Procedures |
Materials
[14C]Cefixime (44.7 mCi/mmol) and
unlabeled cefixime were provided by Klinge-Pharma (Munich, Germany) and
Fujisawa (Osaka, Japan). Flavonoids were purchased from Sigma
(Deisenhofen, Germany) or Phytochem (Ischenhausen, Germany). Luteolin,
tangeretin, and diosmetin were from Roth (Karlsruhe, Germany), and
lavendustin A, genistein, and daidzein were from Calbiochem (Bad Soden,
Germany). Tyrphostin 25 and amiloride were obtained from Sigma. Cell
culture plates and flasks were obtained from Nunc (Wiesbaden, Germany).
All other materials needed for cell culture were from Invitrogen
(Eggenstein, Germany). Rat tail collagen R was purchased from Serva
(Heidelberg, Germany).
Methods
Cell Culture.
Caco-2 cells (ATCC, HTB 37, passage 31) were
cultured and passaged in Dulbecco's modified Eagle's medium
(Invitrogen) supplemented with 10% fetal calf serum, 2 mM glutamine,
1% minimum essential medium nonessential amino acids (Invitrogen), and
70 µg/ml gentamicin (Invitrogen) in a humidified incubator at 37°C
under an atmosphere of 5% CO2. Cells between
passages 40 and 65 were seeded at a density of 1 · 105 cells/well onto Transwell polycarbonate
membranes (24-wells, Nunc) and were used 14 days after reaching
confluency. Fresh medium was given every 2nd day, and on the day before
uptake measurements were performed. Transepithelial electrical
resistance was measured with an epithelial voltmeter (EVOM,
World Precision Instruments, Berlin, Germany) and resistances of
300
/cm2 indicated the presence of an intact
monolayer (Artursson, 1990
; Riley et al., 1991
).
Transport Studies.
Flux studies in Caco-2 cells were
performed in a modified Krebs' buffer containing 137 mM NaCl, 5.4 mM
KCl, 2.8 mM CaCl2, 1.0 mM
MgSO4, 0.3 mM
NaH2PO4, 0.3 mM
KH2PO4, 10 mM glucose, and 10 mM HEPES-Tris for incubation buffer pH 7.4 or 10 mM
2-(N-morpholino) ethane-sulfonic-acid-Tris for incubation
buffer pH 5.0, respectively. For uptake, cell monolayers were washed
free of serum-containing medium and incubated from the apical side of
the monolayer with radiolabeled [14C]cefixime
in the presence or absence (control) of flavonoids for 30 min at
37°C. The basolateral side of the monolayers was incubated with
incubation buffer pH 7.4. After the incubation period, the cells were
washed three times with ice-cold incubation buffer and subsequently
digested with a tissue solubilizer. Cellular accumulation of
[14C]cefixime was measured after the addition
of scintillation cocktail by liquid scintillation spectroscopy. Binding
of tracer to the cells was determined as the residual radioactivity
associated with the cells in the presence of excess unlabeled
substrate. The basic characteristics of cefixime transport in the
Caco-2 cell model have been reported previously (Wenzel et al., 1996
).
pHin Measurements.
For
pHin measurements, the Caco-2 monolayers were
loaded with BCECF by preincubating the cells with 5 µM the lipophilic
acetoxymethyl-ester at 37°C for 30 min. Subsequently, the monolayers
were washed with buffer pH 7.4, and the buffers with or without
substrates were changed by superfusion at the time points indicated in
the graphs. Intracellular H+ activity was
determined by intensity of emission at 538 nm after excitation of the
fluorophore at 444 nm (isosbestic point) and 490 nm (pH sensitive
wavelength), respectively, using a microtiter plate reader (Fluoroskan
Ascent, Labsystems, Merlin Diagnostika, Bornheim-Hersel, Germany). The
444/490 fluorescence ratio was converted to pHin
from a calibration curve generated by estimation of the fluorescence
ratio in buffers of different pH (Boyarsky et al., 1996
).
Calculations and Statistics.
All calculations (linear as
well as nonlinear regression analysis) were performed by using Prism
2.01 (GraphPad Software, Los Angeles, CA). For each variable, 4 to 8 independent experiments were carried out. Data are given as the
mean ± S.E.M. Significance of differences between control and
treated cells were determined by an unpaired Student's t test.
 |
Results |
In a first set of experiments, 33 flavonoids of the flavone,
flavonol, flavanone, and isoflavone subclasses (Fig.
1) were tested for their effects on
[14C]cefixime uptake into Caco-2 cells at
apical pH 5.0, where transport of the dianionic
-lactam is optimal
(Wenzel et al., 1996
). At a concentration of 100 µM, the flavones
acacetin, chrysin, and diosmin, the flavonol quercetin, the flavanone
naringin, and the isoflavone genistein increased uptake of 1 mM
cefixime by 25 to 37% (Table 1). All
other flavonoids tested were either without significant effects or even
reduced [14C]cefixime absorption (Table 1).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Four subclasses of flavonoids. The basic structure of
flavonoids consists of an O-heterocyclic ring (C) fused
to an aromatic ring (A) and by a carbon-carbon bond to a second
aromatic ring (B). The classification is based on variations on the
heterocyclic C-ring.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1
Effects of flavonoids on the uptake of [14C]cefixime into
Caco-2 cells
Uptake of 1 mM cefixime was measured at apical buffer pH 5.0 for 30 min
in the absence (control) or presence of 100 µM the respective
flavonoid. Control uptakes were 11.8 ± 3.2 nmol · cm 2 · 30 min 1. Values are expressed
as the mean ± S.E.M. (n = 4).
|
|
Dose-response relationships for those flavonoids that increased the
uptake of 1 mM cefixime revealed EC50 values
ranging between 12.6 and 155.7 µM with maximal stimulation of
transport rates exceeding that in control cells by 50 to 60% (Fig.
2). Similar stimulatory effects on
cefixime uptake by these flavonoids were found at apical pH 6.0, indicating that the stimulatory mechanism is also operational under
less acidic pH conditions (data not shown). Since quercetin showed a
pronounced effect and occurs in comparably large quantities in fruits
and vegetables (Hertog et al., 1992
) we selected this
compound for further analysis of the underlying mechanisms of transport
activation. Kinetics of [14C]cefixime transport
into Caco-2 cells determined in the absence or the presence of 100 µM
quercetin revealed that Vmax was
significantly increased by the flavonoid without any effects on the
Km (Fig. 3). Transformation of the data according
to Eadie-Hofstee revealed a maximal transport rate increased by 53% in
the presence of quercetin (Fig. 3, inset). Such an increase could
either be due to direct modifications of the PEPT1 protein allowing a
higher turnover rate or by alterations of its driving force. Since the
transmembrane pH gradient across the apical plasma membrane is required
for the H+-coupled uptake of short-chain peptides
and
-lactam antibiotics mediated by PEPT1 (Thwaites et al., 1993a
,b
;
Wenzel et al., 1996
), quercetin and other flavonoids might stimulate
cefixime absorption indirectly by alterations of the proton-motive
driving force.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 2.
Screening for the effects of selected flavonoids on
[14C]cefixime uptake into Caco-2 cells. Cells were
incubated for 30 min with 1 mM cefixime at apical buffer pH 5.0 either
in the absence (control) or presence of 0.1 to 750 µM flavonoid (A,
acacetin; B, chrysin; C, diosmin; D, quercetin; E, naringin; F,
genistein). EC50 values for stimulation of cefixime
transport derived from the dose-response curves were 109.0 ± 2.6 µM for acacetin, 114.5 ± 3.2 µM for chrysin, 155.7 ± 5.6 µM for diosmin, 17.5 ± 1.6 µM for quercetin, 66.6 ± 1.3 µM for naringin, and 12.6 ± 0.8 µM for genistein,
respectively. Uptake of cefixime into control cells was 7.6 ± 2.1 nmol · cm 2 · 30 min 1. Results
are expressed as the mean ± S.E.M. of four independent
experiments.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Uptake of [14C]cefixime into Caco-2
cells as a function of substrate concentration. Transport of 0.05 to 5 mM cefixime was measured for 30 min at pH 5.0 either in the absence
( ) or in the presence ( ) of 100 µM quercetin. Transformation of
the transport rates according to Eadie-Hofstee analysis (inset)
revealed Km and
Vmax values of 1.5 ± 0.2 mM and
30.0 ± 1.7 nmol · cm 2 · 30 min 1 in control cells and 1.4 ± 0.2 mM and
45.9 ± 3.2 nmol · cm 2 · 30 min 1 in quercetin-treated cells, respectively.
|
|
We therefore used BCECF to determine whether exposure of cells to the
test compounds altered the intracellular pH in Caco-2 cells, which is a
critical determinant of the driving force of PEPT1. The measurement of
pHin in Caco-2 cells superfused either with
apical buffer pH 5.0 alone or in addition with 5 mM cefixime revealed
that transport of cefixime caused as expected a further pHin decline as compared with perfusion with
buffer alone (Fig. 4). However, when
quercetin was coadministered, the pHin decline by
cefixime was less pronounced (Fig. 4), although under this conditions
H+/cefixime cotransport is significantly higher
(Table 1; Fig. 3). This strongly suggested that transport systems
responsible for the maintenance of the transmembrane pH gradient, such
as apical Na+/H+-exchange
(NHE), could be activated by quercetin. To show that quercetin indeed
enhances cefixime absorption by activation of apical
Na+/H+-exchange, we used
100 µM the NHE blocker amiloride. In the presence of amiloride,
quercetin was no longer able to stimulate cefixime transport (Fig. 4,
inset).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
pHin measurements in Caco-2 cells using
the pH sensitive fluorophore BCECF. Cells were superfused from the
apical side with buffer pH 7.4 for 5 min. Subsequently, cells were
perfused for 30 min with buffer pH 5.0 ( ) containing either buffer
alone ( ) or in addition to ( ) 5 mM cefixime or a mixture of 5 mM
cefixime and 100 µM quercetin ( ). All substrates were washed out
after 35 min followed by perfusion with buffer pH 7.4 ( ). Inset,
relative uptake rates of [14C]cefixime into Caco-2 cells
after 30 min of incubation with either 100 µM amiloride ( ) or 100 µM amiloride plus 100 µM quercetin ( ) at an apical pH of 5.0 and
expressed as a percentage of control uptake ( ). Uptake rates in
cells incubated either with amiloride or with amiloride plus quercetin
did not display significant differences.
|
|
It has been shown recently that NHE-3 is the
Na+/H+-exchanger isoform in
the apical membrane of differentiated Caco-2 cells that is
preferentially activated for pHin control
following PEPT1-mediated H+ influx into cells
(Thwaites et al., 1999
). The NHE-3 protein is subject to regulation by
protein kinases such as protein kinase C, protein kinase A,
phosphatidylinositol 3-kinase, and protein tyrosine kinases (PTK) of
the receptor and nonreceptor subtypes (Good, 1995
; Kandasamy et al.,
1995
; Yamaji et al., 1995
; Khurana et al., 1996
; Good et al., 2000
).
Since genistein proved to be a specific inhibitor of the EGF-receptor
(EGFR) PTK (Akiyama et al., 1987
), and since quercetin is also used as
an inhibitor of EGFR PTK (Traxler et al., 1999
), one possible mechanism
for stimulation of cefixime transport by those flavonoids might be the
activation of NHE-3 via inhibition of EGFR PTK that in turn would allow
a more efficient pHin control. To prove this
hypothesis, we used the specific EGFR PTK inhibitor tyrphostin 25 and
determined its effects on H+/cefixime
cotransport. As shown in Fig. 5,
tyrphostin 25 reduced the acidification induced by cefixime but at the
same time increased cefixime transport rate by 43% (Fig. 5, inset).
This finding suggests a common mode of action for tyrphostin 25 and
also for the flavonoids in maintaining the proton-motive driving force
for PEPT1 through an activation of NHE-3 activity via inhibition of
EGFR PTK.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of tyrphostin 25 on cefixime-mediated
intracellular acidification and on cefixime transport. After perfusing
the cells with buffer pH 7.4 for 5 min, superfusion was performed for
30 min with buffer pH 5.0 ( ) containing either 5 mM cefixime ( )
or a mixture of 5 mM cefixime and 10 µM tyrphostin 25 ( ). All
substrates were washed out after 35 min of incubation with buffer pH
7.4 ( ). Inset, uptake of [14C]cefixime into Caco-2
cells as measured for 30 min at pH 5.0 either in the absence (control,
) or in the presence ( ) of 10 µM tyrphostin 25. **P < 0.01 versus the control.
|
|
 |
Discussion |
Our present findings provide the first evidence for an interaction
of food-derived flavonoids with the intestinal peptide transporter
PEPT1, which mediates the absorption of a variety of drugs including
-lactams (Wenzel et al., 1995
), angiotensin-converting enzyme
inhibitors (Boll et al., 1994
), bestatins (Saito and Inui, 1993
), as
well as special prodrugs (Sawada et al., 1999
). Selected flavonoids may
therefore have the potential to significantly alter the oral
availability and pharmacokinetics of these PEPT1 substrates when
coadministered in humans. Similar interactions have been shown to exist
between several flavonoids and the intestinal drug efflux pumps
P-glycoprotein (Castro and Altenberg, 1997
; Conseil et al., 1998
;
Mitsunaga et al., 2000
; Sadzuka et al., 2000
) and the multidrug
resistance-associated proteins (Hooijberg et al., 1997
; Walgren et al.,
2000
) leading to alterations in the extent of absorption of those drugs
that are substrates of these drug efflux pumps (Seelig, 1998
;
Seelig et al., 2000
).
We show here that a variety of flavonoids out of the flavone, flavonol,
flavanone, and isoflavone subgroups can increase or decrease
PEPT1-mediated cefixime transport in Caco-2 cells. Of the 33 flavonoids
tested, the flavones acacetin, chrysin, and diosmin, the flavonol
quercetin, the flavanone naringin, and the isoflavone genistein
significantly increased the uptake of cefixime into Caco-2 human
intestinal epithelial cells. In contrast, the flavonols 3-OH-flavone,
kaempferol, luteolin, and morin, the flavanone didymin, and the
isoflavone daidzein significantly reduced cefixime absorption. All
other flavonoids had no significant effects on cefixime uptake. With
emphasis on genistein and quercetin, which are present in larger
quantities in a variety of fruits and vegetables, we focused on the
mechanisms by which they transmit the effects on PEPT1. In addition,
increasing the oral availability of
-lactams such as cefixime that
possess an intrinsically low oral availability by means of selected
flavonoids could be beneficial for more effective antimicrobial treatment.
Quercetin was dose dependently able to increase cefixime transport by
increasing the Vmax of PEPT1 but was
at the same time able to reduce the intracellular acidification caused
by cefixime influx and thereby maintained a higher electrochemical
proton gradient across the apical plasma membrane, allowing higher
transport rates. Since quercetin and especially genistein are
frequently used as inhibitors of EGFR PTK (Akiyama et al., 1987
;
Traxler et al., 1999
), we supposed that such an activity might be
responsible for the stimulation of cefixime transport caused by the
flavonoids. Blocking EGFR PTK with the specific inhibitor tyrphostin 25 simulated the effects of the flavonoids most likely by stabilizing the
transmembrane pH gradient required for PEPT1 function and thereby
allowing increased H+/cefixime influx.
Maintenance of the proton-motive driving force for cefixime uptake is
most likely achieved by activation of NHE-3 because this exchanger
subtype was identified functionally in the apical membrane of
differentiated Caco-2 cells to be the prime pH recovery system
activated by PEPT1-mediated acid loading of cells (Thwaites et al.,
1999
). Although it was demonstrated that inhibitors of EGFR PTK, such
as genistein or herbimycin A, stimulated NHE-3 in the apical membrane
of cells from the rat medullary thick ascending limb (Good, 1995
; Good
et al., 1999
), EGF was found to stimulate
Na+/H+-exchange in the
apical membrane of rabbit ileum as well as in Caco-2 cells stably
transfected with NHE-3 (Khurana et al., 1996
; Janecki et al., 1999
).
Irrespective of this apparent contradiction, our studies show that the
specific inhibition of EGFR PTK in Caco-2 cells enhanced
H+ extrusion out of the cells and allowed a
higher PEPT1 transport rate. It is noteworthy in this context that the
physiological regulation and function of epithelium-specific NHEs are
dependent on tissue-specific factors and/or conditional requirements as well (McSwine et al., 1998
).
For inhibition of EGFR PTK, some structural requirements must be
fulfilled by the respective flavonoids. According to a recently proposed pharmacophore model, hydrogen bonding between functional groups of inhibitors and two residues of the hinge region of EGFR PTK
(dual hydrogen bond donor-acceptor system; Traxler et al., 1999
) is an
important requirement. When applied to the flavonoids, the keto
function at position 4 of ring C (see Fig. 1) could generally act as a
hydrogen bond acceptor, whereas the 5-OH group in genistein and the
3-OH group in quercetin could serve as donor groups. Moreover, the 7-OH
group was found to be important for the EGFR PTK inhibitory activity of
isoflavones (Traxler et al., 1999
). These structural features were also
found as a common feature in the five flavonoids that stimulated
cefixime absorption (Table 2). All of
these transport-enhancing structures bear OH groups in the 5- and
7-positions of ring A. In contrast, flavonoids missing one or both of
the 5- and 7-OH substituents generally were not able to stimulate
cefixime absorption (Table 2). However, such a restriction to the
effects of OH groups at positions 5, 7, and 3 (position 3 in the case
of flavonols only) would mean an oversimplification since there were
flavonoids bearing OH groups at these positions but showed no or only
minor transport effects (Table 2). That other structural features and most likely a specific hydroxylation pattern of the flavonoids must
play an important role becomes obvious by inspection of the flavonol
subgroup where quercetin was the only compound found to stimulate
cefixime uptake (Table 2).
In conclusion, five flavonoids of 33 tested were able to significantly
and dose dependently increase cefixime uptake into Caco-2 cells.
Comparing the chemical structures of the different flavonoids reveals
that their effects on cefixime transport match the requirements for
their ability to inhibit EGFR PTK. The effects of tyrphostin 25, a
specific EGFR PTK inhibitor, on maintenance of the proton-motive
driving force for cefixime uptake resemble those observed for the
flavonoid quercetin and suggest a common mode of action. Inhibition and
stimulation of PEPT1-mediated drug transport by flavonoids should be
considered as another example for drug-food interactions of
therapeutical importance.
Accepted for publication July 5, 2001.
Received for publication April 30, 2001.
This study was supported by Klinge-Pharma (Munich, Germany) and
Fujisawa (Osaka, Japan).